After CMS released its finalized 2025 physician fee schedule, which will reduce reimbursements by 2.83%, some cardiologists are raising concerns over what they call an unstable healthcare system, according to a Dec. 9 TCTMD report.
Cardiology
Experts agree more care should be given to cardiovascular safety concerns during clinical cancer trials. The Cardiovascular Safety Research Consortium published new recommendations for addressing those concerns Dec. 10 in JACC: CardioOncology.
The American College of Cardiology has developed an Expert Consensus Decision Pathway for the diagnosis and management of adult patients with acute myocarditis. The pathway was published Dec. 10 in the Journal of the American College of Cardiology.
Charleston, W.Va.-based Vandalia Health’s Mon Health Heart & Vascular Center has launched a new telecardiology service in partnership with the system's Webster Springs, W.Va.-based Webster Memorial Hospital.
Auburn (N.Y.) Community Hospital broke ground on an expansion to its heart institute while launching a $50 million fundraising campaign to support additional improvement projects, according to a Dec. 6 report from The Citizen.
Advertisement
Auburn (N.Y.) Community Hospital broke ground on an expansion to its heart institute while launching a $50 million fundraising campaign to support additional improvement projects, according to a Dec. 6 report from The Citizen.
A team at Austin, Texas-based St. David's Medical Center became the first team in the U.S. to use a newly FDA-approved novel pulsed field ablation system to treat patients with atrial fibrillation.
A team at HonorHealth Scottsdale (Ariz.) Shea Medical Center performed the state's first tricuspid valve replacement using the Edwards Lifesciences' Evoque system outside of a clinical trial.
Cardiologists from Pediatrix Cardiology Associates and the Tampa Bay Adult Congenital Heart Center have joined Clearwater, Fla.-based BayCare Health System's physician practice, BayCare Medical Group.
Using an AI-powered electrocardiogram to diagnose low ejection fraction produced a cost-effectiveness ratio of $27,858 per quality-adjusted life year, according to a study published Oct. 25 in Mayo Clinic Proceedings: Digital Health.